REQUEST A DEMO
Total
USD $0.00
Search more companies

Vance Bioenergy Sdn Bhd (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Vance Bioenergy Sdn Bhd Profile Updated: October 12, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Vance Bioenergy Sdn. Bhd. manufactures bacterial and virus vaccines, toxoids, and analogous products. The company was founded in 2005 and based in Pasir Gudang, Johor, Malaysia.

Headquarters
Plo 668 & 669, Jalan Keluli 5 Kawasan Perindustrian Pasir Gudang 81700 Pasir Gudang Johor
Pasir Gudang; Johor; Postal Code: 81700

Contact Details: Purchase the Vance Bioenergy Sdn Bhd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vance Bioenergy Sdn Bhd report to view the information.
Registered Capital:
Purchase the Vance Bioenergy Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Vance Bioenergy Sdn Bhd report to view the information.
Ratings:
Purchase the Vance Bioenergy Sdn Bhd report to view the information.
Incorporation Date:
September 09, 2005
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Vance Nutraceuticals Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Vance Bioenergy Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
3.2%
Total operating revenue
3.2%
Net Profit (Loss) for the Period
40.75%
Total assets
8.7%
Total equity
0%
Net Profit Margin
1.24%
Return on Equity (ROE)
35.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?